Veranex Unveils MedTech's First Innovation CRO (iCRO)--Redefining R&D in a Capital‑Tight Market
Summary by Financial Post
2 Articles
2 Articles
Veranex Unveils MedTech's First Innovation CRO (iCRO)--Redefining R&D in a Capital‑Tight Market
RALEIGH, N.C. -- Veranex, a global provider of product development and contract research services, today introduced the industry’s first Innovation CRO (iCRO)—an integrated development and research platform engineered to move medical devices and in-vitro diagnostics (IVDs) from concept to commercial success faster, with tighter budget control and a built-in path to payer adoption.
·Canada
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium